Market Value696,301,000
Total Holdings47
File Date2015-11-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
TSRO / TESARO, Inc.
INCY / Incyte Corporation
ARAV / Aravive, Inc.
WGBS / WaferGen Bio-Systems, Inc.
KERX / Keryx Biopharmaceuticals, Inc.
NDRM / NeuroDerm Ltd.
NBIX / Neurocrine Biosciences, Inc.
MACK / Merrimack Pharmaceuticals, Inc.
OCRX / Ocera Therapeutics, Inc.
0HBB / Aimmune Therapeutics Inc
CHRS / Coherus Oncology, Inc.
AMGN / Amgen Inc.
SCYX / SCYNEXIS, Inc.
PBYI / Puma Biotechnology, Inc.
JUNO / Juno Therapeutics, Inc.
SCMP / Sucampo Pharmaceuticals, Inc.
TTOO / T2 Biosystems, Inc.
/ Array BioPharma, Inc.
CASC / Cascadian Therapeutics, Inc.
ZYNE / Zynerba Pharmaceuticals Inc
DRRX / DURECT Corporation
TROV / TrovaGene, Inc.
BNTC / Benitec Biopharma Inc.
VTAE / Vitae Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
OREX / Orexigen Therapeutics, Inc.
RGEN / Repligen Corporation
SRRA / Sierra Oncology Inc
AGRX / Agile Therapeutics, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
ZSPH / ZS Pharma, Inc.
TENX / Tenax Therapeutics, Inc.
MDCO / Medicines Company
ACAD / ACADIA Pharmaceuticals Inc.
TRVN / Trevena, Inc.
ARDX / Ardelyx, Inc.
LUMO / Lumos Pharma, Inc.
ABUS / Arbutus Biopharma Corporation
SIOX / Sio Gene Therapies Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
TGTX / TG Therapeutics, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
ARMP / Armata Pharmaceuticals, Inc.
TXMD / TherapeuticsMD, Inc.
DYAX / Dyax Corp.
RGLS / Regulus Therapeutics Inc.
ABIO / ARCA biopharma, Inc.
SGMO / Sangamo Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc. Call
COLL / Collegium Pharmaceutical, Inc.
DRNA / Dicerna Pharmaceuticals Inc
NTRA / Natera, Inc.
BPMC / Blueprint Medicines Corporation
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
ZGNX / Zogenix Inc
AKBA / Akebia Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
GBT / Global Blood Therapeutics Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
CELG / Celgene Corp.
CLVS / Clovis Oncology Inc
EPZM / Epizyme Inc
PTCT / PTC Therapeutics, Inc.
BIIB / Biogen Inc.
LRMR / Larimar Therapeutics, Inc.
BLUE / bluebird bio, Inc.
ALPN / Alpine Immune Sciences, Inc.
RMTI / Rockwell Medical, Inc.
OMER / Omeros Corporation
US00448Q2012 / Achillion Pharmaceuticals, Inc.
AGEN / Agenus Inc.
AGTC / Applied Genetic Technologies Corp
ITCI / Intra-Cellular Therapies, Inc.
NLTX / Neoleukin Therapeutics, Inc.
H03579101 / Auris Medical Holding Ltd
MCRB / Seres Therapeutics, Inc.
CDTX / Cidara Therapeutics, Inc.
BBI / Brickell Biotech Inc
NVAX / Novavax, Inc.
ALKS / Alkermes plc
XNCR / Xencor, Inc.
DVAX / Dynavax Technologies Corporation
TARA / Protara Therapeutics, Inc.
CNCE / Concert Pharmaceuticals Inc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
VXRT / Vaxart, Inc.